Endothelin-1 urinary excretion, but not endothelin-1 plasma concentration, is increased in renovascular hypertension.
Animal experiments have shown an increase in prepro-endothelin-1 (prepro-ET-1) mRNA expression in the clipped kidney but none in the aortic and mesenteric arteries in 2-kidney, 1-clip Goldblatt hypertensive rats. The present study was aimed at investigating whether plasma and renal endothelin-1 (ET-1) systems are differently activated in patients with renovascular hypertension (RH). The plasma concentration and urinary excretion of ET-1 were measured in 5 patients with RH (before and after successful renal angioplasty), in 7 patients with essential hypertension (EH), and in 8 normotensive control subjects. Immediately before renal angioplasty, plasma samples for ET-1 and plasma renin activity (PRA) measurements were withdrawn from the aorta and both renal veins. Unlike the PRA, the plasma ET-1 concentration did not significantly differ between the involved and the uninvolved sides. The urinary ET-1 excretion level (Fig 1) was markedly increased in patients with RH (30+/-4 ng/g urinary creatinine (UC) vs. 2.5+/-0.2 ng/g UC and 2.6+/-0.5 ng/g UC in control subjects and patients with EH, respectively; P<.001), whereas the plasma ET-1 concentration was normal (0.8+/-0.2 pg/mL vs. 0.65+/-0.3 pg/mL and 0.8+/-0.2 pg/mL in control subjects and EH, respectively, not significant). Renal angioplasty was followed in all patients by normalization of blood pressure and PRA. One week after angioplasty, urinary ET-1 decreased to one fourth of baseline (8.04+/-5.23 ng/g UC, P<.001 vs. values before angioplasty and P<.04 vs. control subjects) and normalized 1 month thereafter (3.13+/-1.62 ng/g UC, not significant vs. control subjects), whereas plasma ET-1 remained steady. The present findings clearly indicate that in patients with RH, urinary ET-1 excretion is increased, whereas plasma ET-1 concentration remains normal. Successful percutaneous transluminal renal angioplasty induced a notable reduction in ET-1 urinary excretion, whereas it did not affect ET-1 plasma concentration.
Cecioni
I
I
Clinica Medica Generale e Cardiologia, University of Florence, Italy.
Modesti
P A
PA
Poggesi
L
L
Rocchi
F
F
Rega
L
L
Neri Serneri
G G
GG
D000368:Aged; D000450:Aldosterone / Q000097:blood; D017130:Angioplasty; D001161:Arteriosclerosis / Q000601:surgery; D001794:Blood Pressure; D004452:Echocardiography; D019332:Endothelin-1 / Q000097:blood* / Q000652:urine*; D005260:Female; D006801:Humans; D006977:Hypertension, Renal / Q000097:blood* / Q000601:surgery / Q000652:urine*; D008297:Male; D008875:Middle Aged; D016277:Ventricular Function, Left
D019332:Endothelin-1; D000450:Aldosterone